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Initiated by CREB: Resolving Gene Regulatory Programs in
Learning and Memory
Switch in Cofactors and Transcription Regulators between Memory Consolidation
and Maintenance Network
Jenifer C. Kaldun and Simon G. Sprecher*
Consolidation of long‐term memory is a highly and precisely regulated
multistep process. The transcription regulator cAMP response element‐binding
protein (CREB) plays a key role in initiating memory consolidation. With time
processing, ﬁrst the cofactors are changed and, secondly, CREB gets
dispensable. This ultimately changes the expressed gene program to genes
required to maintain the memory. Regulation of memory consolidation also
requires epigenetic mechanisms and control at the RNA level. At the neuronal
circuit level, oscillation in the activity of CREB and downstream factor deﬁne
engram cells. Together the combination of all regulation mechanisms allows
correct memory processing while keeping the process dynamic and ﬂexible to
adjust to diﬀerent contexts. Also see the video abstract here https://youtu.be/
BhSCSmorpEc.
1. Introduction
The ability to form and store memories requires lasting changes
within deﬁned neural circuits. These modiﬁcations are assumed
to occur by regulating the strength of speciﬁc synaptic connec-
tions.[1,2] The molecular mechanisms that underlie learning
processes are evolutionarily conserved and shared between
invertebrates and vertebrates.[3,4] Much of the molecular and
genetic understanding stems from studies in model organisms
such as the sea snail Aplysia californica, the fruit ﬂy Drosophila
melanogaster (D. melanogaster), the nematode Caenorhabditis elegans
(C. elegans), as well as mice and rats.[5–11] Diﬀerent forms and
phases of memories can be roughly divided into short‐term
memories (STMs) and long‐term memories (LTMs).[6,12] STM is
based on transient post‐translational modiﬁcations at synapses,
whereas LTM typically requires de novo protein biosynthesis.[4,6]
This so‐called long‐term synaptic plasticity can either strengthen
synapses (long‐term potentiation [LTP]) or
weaken synapses (long‐term depression
[LTD]).[13] It is well established that the
consolidation of STM to LTM requires gene
transcription and RNA translation.[4,6,14]
Thus, changes in the gene regulatory
program are a critical process for proper
LTM formation. While the early mechan-
isms that link neuronal activity with
changes of gene expression are well studied,
little is as yet known about the changes in
the transcriptional program that allows
long‐lasting memories to be formed and
maintained.
Important studies in Aplysia and D.
melanogaster led to the discovery of the
adenyl kinase (AC)→cAMP→protein ki-
nase A (PKA) pathway as a key player in
synaptic plasticity, learning, and memory. These results were
also conﬁrmed in mouse and rat models, emphasizing how
evolutionarily conserved the mechanism is.[3,15,16] PKA is
known to activate the cAMP response element‐binding proteins
(CREB), a family of conserved transcription factors (TFs).[16]
Indeed, manipulations of CREB lead to memory defects.
Strikingly, downregulation of CREB impairs memory whereas
overexpression enhances memory.[3,15,16] Therefore, the cyclic
adenosine monophosphate (cAMP) signaling pathway is
considered a key player in learning and memory. Ca2+ ions
from voltage‐gated ion channels also act as a messenger.[17]
Interestingly, CREB can also be activated by Ca2+ signal-
ing.[18,19] As a consequence, CREB is able to integrate multiple
types of information to regulate gene expression.[19]
Synaptic plasticity may be accompanied by structural
plasticity, changing the size and shape of the synaptic ending.
In the presynapse, synaptic plasticity changes the amount of
released transmitter, whereas in the postsynapse the amount of
neurotransmitter receptors is adapted.[13,20]
Even though CREB is well studied in diﬀerent model
animals, the downstream processes leading to LTM are not
understood completely. Recent studies show that molecular
processes involved in LTM consolidation and plasticity involve
additional gene regulatory mechanisms. Epigenetic mechan-
isms such as DNA methylation and histone acetylation[21,22] as
well as the role of cofactors[23,24] are gaining importance.
Moreover, recent evidence suggests that CREB initiates a gene
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regulatory cascade, which appears to be critical for long‐lasting
memories.[23,25] Thus, CREB provides an early entry point and a
critical link to a gene regulatory program in LTM. In this
review, we ﬁrst focus on how CREB is regulated and how it
functions and then provide an overview of direct and down-
stream CREB targets. In the second part, we discuss the role of
other gene regulatory mechanisms and how the gene regulatory
networks may control memories.
2. Main Text
2.1. Manifold Mechanisms Fine‐Regulate CREB Activity
The conserved transcription regulator CREB is involved in the
development, cell survival, plasticity, and learning and mem-
ory.[3,11,15,26] CREB belongs to the bZIP family of TFs together
with cAMP responsive element modulator (CREM) and
activating transcription factor 1 (ATF1). These function as
homodimers or heterodimers with other bZIP TFs, allowing the
formation of diﬀerent gene regulatory complexes.[15,26,27] CREB
binds to its recognition sequence, the cAMP response element
(CRE) on promotors of target genes (Figure 1). The CRE
sequence is palindromic, but also half‐canonical CRE sites and
variations are recognized with diﬀerent aﬃnities.[26,28–30] This
suggests that variations in the recognition strength aﬀect the
expression of target genes. Interestingly, CREB genes are
spliced in diﬀerent isoforms, which can function as
transcription activators or repressors. Repressor and activator
isoforms seem to compete for CRE sequences, so the ratio
between them is a part of their gene regulation func-
tion.[5,15,26,31–34] An important step to regulate CREB activity
is by phosphorylation and dephosphorylation.[19,26,35] The ﬁrst
described activator of CREB was the cAMP–PKA signaling
pathway, which phosphorylates CREB1 at Ser‐133.[33,36] The
cAMP–PKA pathway is the main downstream eﬀector of G‐
protein coupled receptors (GPCR), such as dopamine receptors,
which respond to a wide array of ligands[37,38] (Figure 1). This
signaling mechanism is well recognized for its role in learning
and memory from invertebrates to mammals.[16] Besides PKA,
CREB1 is also phosphorylated by Ca2+‐signaling through Ca2+‐
calmodulin‐dependent kinases (CamK).[18,19,34] Ca2+ is impor-
tant in neuronal processes, e.g., through voltage‐gated channels
or glutamate receptors.[17] Another upstream eﬀector of CREB
activation is growth signaling through receptor‐tyrosine kinases
(RTK) and their downstream kinases such as PKB/AKT,
extracellular‐signal‐regulated kinase (ERK), or mitogen‐acti-
vated protein kinase (MAPK)[19,34] (Figure 1). All the mentioned
kinases and other kinases can either phosphorylate CREB at
Ser‐133 or other phosphorylation sites on the protein. In fact,
over 300 stimuli have been reported to aﬀect CREB phosphor-
ylation state.[11,15] Moreover, CREB is subject to further post‐
transcriptional modiﬁcations.[19] CREB is described to be
acetylated, for example, by CREB‐binding protein (CBP), which
is suggested to regulate the duration of phosphorylation.[39]
Figure 1. Regulation of CREB: the CREB TF is activated and phosphorylated by growth factors through RTK, neurotransmitters through GPCRs, or
Ca2+ via glutamatergic NMDA receptors or VGCCs. Downstream of GPCRs is the AC→cAMP→PKA pathway, which can be inhibited by PDEs. The
signaling pathways also regulate phosphatases like PP2A, which can inactivate CREB (PDE). CREB activator isoforms (CREB A) and repressor
isoforms (CREB B) compete for CRE sequence in promotor regions. CREB dimers initiate target gene transcription together with the cofactors CBP
and CRTC. NMDA, N‐methyl‐D‐aspartate; VGCC, voltage‐gated cation channel.
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Another modiﬁcation is glycosylation. It was shown that
glycosylation reduces the transcriptional activity of CREB as
well as aﬀecting its phosphorylation by diﬀerent PKA iso-
forms.[40] In conclusion, post‐transcriptional modiﬁcations
allow the ﬁne‐tuning of CREB by reducing its activity.
Besides becoming phosphorylated by diﬀerent kinases,
dephosphorylation by phosphatases is also involved in regulat-
ing CREB, hence ensuring that target genes are not expressed
constitutively. Both protein phosphatase 1 (PP1) and PP2A have
been reported to dephosphorylate CREB, causing reduced
CREB activity.[15,16,19,41,42] The phosphatases are also involved
in regulating the signaling cascades upstream of CREB, thereby
inﬂuencing it indirectly. CREB activity can also be restricted by
inactivating the signaling cascades that lead to its activation.
The cAMP–PKA signaling pathway can be counteracted by
phosphodiesterases (PDEs) (Figure 1), which break the
phosphodiester bound in the second messenger thereby
inactivating it.[43] Thus, two principles are involved in regulat-
ing CREB activity: balancing phosphorylation and dephosphor-
ylation on CREB and regulating upstream signaling cascades.
Phosphorylation of Ser‐133 enables the recruitment of the
cofactor CBP or its paralog p300.[15,44,45] Besides CBP/p300,
transducer of CREB/CREB‐regulated transcription coactivator
(TORC/CRTC), which consists of three members, can function
as a cofactor for CREB without the requirement of CREB Ser‐
133 phosphorylation for the interaction[46,47] (Figure 1). CREB
requires a cofactor for the activation of gene expression and
formation of the gene regulatory complex. Therefore, the
cofactors and their recruitment are an important step in
regulating transcription, a concept that will be discussed later.
Taken together, CREB regulate the expression of target genes in
response to a broad range of stimuli. The activity of CREB and
the transcription rate of the target genes are ﬁne‐tuned by
regulating CREB itself and the respective signaling cascades. As
a consequence, CREB‐mediated transcription is not merely
“on” or “oﬀ” but displays various degrees in between.
2.2. The Discovery of CREB Target Genes
CREB is an early transcriptional regulator in LTM, hence it is
critical to understand which genes it regulates directly. In the
past, various approaches and models have been used to gain
insight into the target genes of CREB (Figure 2). The assembly
of human and other genomes allowed a genome‐wide search
for CRE sites. By using hidden Markov models on human,
mouse, and rat genomes for cross‐species comparison, about
4100 putative conserved CRE sites close to transcription starts
Figure 2. Screening approaches for CREB targets: schematic representation of the major approaches to identify CREB targets in diﬀerent animal
species. Left: represents in silico analysis of genomes, middle: transcriptomics‐based methods, and right: ChIP methods.
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were identiﬁed[48,49] (Figure 2). The limitations of this approach
are that it does not reveal whether the genes are regulated in
vivo by CREB, or at which developmental stage, or in which
tissue.
Another widely used approach for the identiﬁcation of genes
downstream of CREB, or involved in learning, is transcrip-
tomics, in particular microarrays (Figure 2). In mammals, both
cell cultures[50–52] and dissected brain regions[53–56] have been
used to analyze the transcriptomic proﬁle after stimulation of
CREB. A variety of stimuli have been used to activate the CREB
signaling pathway, for example, forskolin treatment,[51,52] which
activates cAMP‐signaling,[57] constitutive active CREB,[50,53]
electrostimulation,[55,56] or conditioning training.[54] Similar
approaches have also been used in Drosophila,[58,59] Aplysia,[60]
and C. elegans.[61] In Drosophila, selected cells involved in
learning and memory were picked either by patch clamp[62] or
tagged nuclei (INTACT)[63] to obtain cell‐type‐speciﬁc tran-
scriptomic proﬁles. Although these approaches can identify
targets involved in these contexts, it has its limitations. First, it
only captures the temporal transcription proﬁle, whereas the
induced processes are dynamic and show changes in the gene
expression over time. Hence, the choice of timepoint for
analysis can aﬀect the result. Second, this analysis does not
reveal whether the found hit is a direct target or an indirect
target. Last, smaller changes in gene expression might not be
captured.
Chromatin immunoprecipitation (ChIP) has also been used
to discover possible target genes in the cell culture or dissected
brain tissue (Figure 2). In this technique, DNA‐binding
proteins are precipitated with the DNA to which they are
bound. By using an antibody against CREB, the promoters that
it might occupy were identiﬁed.[55,64] Again, it still has to be
veriﬁed that these promotors are truly regulated by CREB.
Besides looking for CREB occupancy, antibodies against the
cofactor CRTC or histone modiﬁcations[23] have also been used
to ﬁnd putative‐active genes in speciﬁc cells.
Recently, another approach was applied to ﬁnd memory‐
relevant genes after LTM induction, namely “targeted DNA
adenine methyltransferase identiﬁcation” (TaDa).[65] For this
approach, a DNA adenine methyltransferase (DAM) is fused to
the RNA polymerase. When the RNA polymerase binds to DNA
the DAM methylates nearby nucleotides, allowing the visualiza-
tion of genes that were transcribed.[65,66]
Together these multiple approaches in diﬀerent model
organisms with diﬀerent conditions, produce a list of putative
CREB targets. The main ﬁndings are summarized in Table 1.
Reassuringly, all studies found known CREB targets or memory
genes such as somatostatin[29] or c‐fos,[74] hence supporting the
validity of the techniques.
Furthermore, in these studies, neuronal genes like neuro-
transmitter receptor subunits or vesicle fusion proteins are
found, consistent with CREB’s role in the neuronal pro-
cesses.[58–61] Moreover, CREB’s reported role in develop-
ment[11,15] is recapitulated by hits such as CDKs (involved in
cell‐cycle regulation) or hox genes. All screens discovered
transcription regulators, for example, egr1, as putative CREB
targets. These seem to be involved in orchestrating the CREB‐
mediated response, as we discuss later. Another group of
targets that was found was one related to signaling, such as
MAPK or PDEs. CREB might, therefore, be involved in
regulating downstream or upstream signaling cascades.
Additionally, these screens also recover genes whose func-
tions are unknown or not associated with neuronal processes.
Other hits have homologs associated with learning in other
species. Hence, testing these hits provides a good basis for a
better understanding of CREB‐regulated processes.
Moreover, similar genes have been found in diﬀerent
species, verifying the conserved role of CREB. These ﬁndings
support the notion that the downstream transcriptional
programs are similar, despite diﬀerent conditions in the
respective screens. This leads to the speculation that there
might be a conserved core program induced by CREB upon
activation. There is still work that needs to be done to verify that
these hits are indeed true CREB targets in vivo. Nevertheless,
there are also diﬀerences, which can partly be attributed to the
approaches but also speak for a more speciﬁc downstream
program depending on species, tissues, and conditions. More-
over, these screens also uncovered putative hits that should be
analyzed in the future.
2.3. What Is Happening Downstream of CREB?
The transcriptional changes initiated by the cAMP pathway
appear not to be static but rather the initiation of a cascade of
events (Figure 3A). It has been shown that there are at least two
waves of gene transcription.[12] Neuronal activity triggers CREB‐
mediated transcription of the so‐called immediate early genes
(IEGs). These IEGs are then responsible for the second wave of
transcription.[12,75,76] Well‐known IEGs that are CREB targets
are the transcription regulators c‐fos,[74] c‐jun,[35] and egr1/
zif268[71] (Table 1). Furthermore, these genes are also used as
markers for neuronal activity.[75] Therefore, the IEGs might be
part of the core program downstream of CREB. Besides
neuronal activity, CREB responds to other signals as well:[19]
it can be speculated that it might be a switch that turns LTM
formation and plasticity on when the context and cellular state
allows it. The IEGs may then regulate speciﬁc changes needed
to establish long‐term plasticity and memory depending on the
state of the neuron. However, it cannot be ruled out that CREB
is also required for the second wave because plasticity‐
associated genes that are more likely to be a target of the
second wave possess CRE promotor sequences as well[48,49]
(Table 1). One possibility would be that CREB repressor
isoforms might inhibit these genes when memory formation
is not happening. A second possibility would be that CREB
requires one of the TFs of the ﬁrst transcription wave as a
partner to activate these genes.
Support for this mechanism comes from the observation that
CREB activity is biphasic, the ﬁrst peak coming shortly after
neuronal activity and the second around 3–6 h later when the
second wave starts.[12] Accordingly, in the ﬁrst round, CREB
turns on the plasticity transcription program context‐speciﬁc,
whereas in the second wave it regulates the genes together with
the IEGs.
Another TF that was found is CCAAT/enhancer binding
protein (C/EBP). In Aplysia, C/EBP plays a role in long‐term
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Table 1. Summary of the discovered CREB target genes: an overview of putative CREB targets from the screen described in Section 2.2.
Category Example genes Species CRE sequence Involved in LTM Reference
Transcription NR4A Mammals Yes Yes [48–52,54,56,61,64,67]
C. elegansa)
NF‐κB Mammals Yes Yes [49,68]
CCAAT/enhancer binding protein Mammals Yes Yes [49,64,69]
Aplysia
CREB All Yes Yes [49,53]
CREM, ICER Mammals Yes Yes [49,50,52,70]
c‐fos Mammals Yes Yes [49–54,56,64]
c‐jun Mammals Yes Yes [49,51,54,56,64]
Egr‐1/zif268/knox24 Mammals Yes Yes [49,51,54,56,60,71]
Aplysia
HDAC Mammals Yes Yes [23,49,56]
Drosophila
CBP Mammals Yes Yes [45,49]
Lmo4/bx Mammals Yes Yes [23,48,49,72,73]
Drosophila
orb [CPEB1] Drosophila unknown Yes [58,63]
Development CDK7 Mammals Yes No [49]
Drosophila
HoxA, HoxB, HoxC Mammals Yes No [49]
Wnt10A Mammals Yes No [48,49]
Signaling SST Mammals Yes unknown [29,48,49,52]
BDNF Mammals Yes Yes [53]
PP1 subunits Mammals Yes Yes [49,56,64]
MAPK Mammals Yes Yes [23,49,64]
Drosophila
PDE Mammals Yes Yes [49,60,61,64]
C. elegans
Aplysia
PKA Mammals Yes Yes [49,51,63]
C. elegans
Drosophila
CAMK Mammals Yes Yes [49,61]
C. elegans
Adenylate cyclase Mammals Yes Yes [48,60,61,63]
C. elegans
Drosophila
Aplysia
Calcineurin Mammals Yes Yes [23,49]
Drosophila
Neurotransmitter subunits AchR Mammals Yes Yes [49,61–63]
C. elegans
Drosophila
GlutR Mammals Yes Yes [49,60–62]
C. elegans
Drosophila
Aplysia
GABAR Mammals Yes Yes [49,61,62,64]
C. elegans
Drosophila
Traﬃcking and synapses ARC Mammals Yes [49,51,56]
(Continued)
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facilitation, and impairment of the gene in mammals causes
memory defects but the exact role of it is not clear.[4,69]
The nuclear receptor subfamily 4 group A (NR4A) is also listed
as putative CREB target[48–52,54,56,61,64,67] (Table 1). The NR4A
group has three members and is known for its role in
development;[77] however, there are also reports that these
transcription regulators are required in memory.[4,67] It is
possible that NR4As are activated in development as well as in
plasticity events by CREB. This raises a question: do the target
genes change between the two processes or are genes required
in development also required in plasticity and memory?
Regardless, a key question is how the transcription regulators
work together, i.e., whether each of them turns on a speciﬁc
transcription program or whether they are required for a
common program.
In conclusion, CREB seems to have at least two roles in
memory consolidation: ﬁrst, it functions as an on‐switch for
plasticity depending on a broad range of signals; second, it is a
TF for memory genes along with the IEGs. This duality could
ensure that consolidation occurs and allows a ﬂexible response
by the combination of the diﬀerent translation regulators.
2.4. CREB Regulates Neuronal Genes
The ultimate aim of memory consolidation is to create long‐
lasting changes in the synapses. Hence, it is not surprising that
synaptic and neuronal genes are among the putative CREB
target genes (Table 1). Synaptotagmin, for example, is a calcium
sensor regulating the formation of the complex required for the
release of neurotransmitter vesicles,[78] whereas Shank and
Homer are scaﬀolding proteins in the postsynapse and therefore
involved in the structure and organization of the synapse.[79]
Changes in these proteins are believed to modulate synaptic
plasticity by adjusting the response of the synapse to neuronal
activity.[13,20] There are two points to be considered in the
regulation of these genes. First, synaptic plasticity happens at
the pre‐ and the postsynaptic membrane.[13,20] Whereas
plasticity on the presynaptic side is characterized by a change
in the neurotransmitter release, the postsynaptic membrane
responds by adjusting the number of receptors, a process
involving diﬀerent proteins from the presynaptic side.[13,20] This
means that the cell has to “know” at which synaptic location the
neuronal activity is happening to respond accordingly. The
molecules that signal from the synapses to the nucleus[80] most
likely already contain the information about the synaptic site, so
they might directly regulate kinases/phosphatases, transcrip-
tion regulators, or epigenetic processes. Second, plasticity can
either enhance or weaken a synapse.[13,20] This means that two
opposite responses are exploited. Again, this suggests modulat-
ing of upstream signaling pathways, the TFs themselves, or
their accessibility to genes. A further observation is that the
transcriptional program downstream of CREB is not always
identical but varies.[51,56]
Among the putative CREB targets are subunits of the major
neurotransmitter receptors such as acetylcholine, glutamate, or
γ‐aminobutyric acid (GABA). However, neurons diﬀer in the
neurotransmitter system that they use. This proposes that
neuronal genes are diﬀerentially regulated in speciﬁc neuron
types. The diﬀerences between neuronal cell types might be
determined during neuronal diﬀerentiation via epigenetic
mechanisms, making unused genes inaccessible to transcrip-
tion. On the other hand, recent single‐cell RNAseq studies have
shown that there could be neurons that use more than one
neurotransmitter system in parallel,[81] so the downstream
program of CREB must be able to discriminate which system is
in use at a given time.
CREB and its transcriptional regulatory network have to
ensure the proper consolidation of memory and appropriate
changes for synaptic plasticity while adjusting the response to
neuron type and synaptic site. This seems to be realized by the
synapse‐to‐nucleus signaling mechanism adjusting upstream
signaling pathways, transcription regulators, and epigenetic
processes accordingly.
2.5. How to Update a Memory Trace
Section 2.4 described how CREB and the IEGs could regulate
neuronal genes. However, CREB and its downstream factors
could also be involved in regulating the upstream processes.
Both CREB family members and components of CREB‐
regulating signaling cascades are putative targets (Table 1).
The most prominent example is the CREM isoform inducible
cAMP early repressor (ICER). ICER is an IEG and functions as
a transcriptional repressor. As ICER also uses CRE sequences it
could inhibit CREB‐mediated transcription.[15,70,82] However,
CREB activator isoforms seem to be required for the second
wave of transcription,[12] so repressor isoforms might be
required for selecting the target genes by inhibiting those that
Table 1. (Continued)
Category Example genes Species CRE sequence Involved in LTM Reference
In rodents, not
in humans
Synaptotagmin Mammals Yes Yes [49,52,60,63,64]
Aplysia
Homer Mammals Yes Yes [49]
Shank Mammals Yes Yes [49,61,64]
C. elegans
a)The found gene is a homolog to the mammalian gene.
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are not required. Members of the cAMP–PKA signaling
pathway or other upstream pathways could be regulated during
consolidation, for example, negatively by promoting PDEs to
restrict CREB activity, or positively by promoting the expression
of cascade members to sustain or amplify CREB activity. The
upregulation of signaling pathways might further allow
updating or halting of the memory consolidation process when
new information is relayed to the neuron. Furthermore, this
suggests that the signaling pathways could also be required to
ﬁne‐tune the second wave by regulating the respective TFs and
cofactors, allowing modulation or cessation of LTM formation
as well. This might be dependent on which training paradigm is
used. In Drosophila, classical olfactory conditioning (where an
odor is paired with an unconditioned stimulus) is used for
training. Aversive conditioning requires multiple training
session with breaks in between to generate LTM.[83] Hence,
LTM might require a switch between active and inactive CREB
signaling, which could be achieved by changing between
repressor and activator forms or turning signaling pathways
on and oﬀ. Appetitive conditioning requires only one training
session.[84] However, appetitive LTM is only formed when the
sugar has nutritional value. This information was shown to be
relayed to the mushroom body (MB) after ingestion, so a few
hours after the original association was made.[85,86] It, therefore,
Figure 3. TFs and cofactors of CREB: A) Depending on the synaptic activity and the context, CREB will activate or not transcription. IEGs like c‐fos,
jun, egr1, and so on are TFs themselves and turn on their target genes in combination with CREB. B) The formation of LTM requires CREB and its
cofactor CBP. Early maintenance (day 4 in Drosophila) still depends on CREB but requires CRTC instead of CPB. Later maintenance (day 7 in
Drosophila) is completely independent of CREB and requires Bx.
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appears that neurons involved in the memory trace need to stay
prepared to continue the consolidation process when the sugar
is nutritious or stop the process when it is not.
CREB could regulate itself and the upstream signaling
pathway positively and negatively, thereby ﬁne‐tuning the
cellular response by allowing updates or stops of the
consolidation process.
2.6. ARC Could Transfer Messenger RNA (mRNA) between
Neurons
A quite interesting CREB target is activity‐regulated cytoskele-
ton‐associated protein ARC/ARG3.1. The protein is involved in
the traﬃcking of AMPA receptors and impairing ARC leads to
LTM defects.[87] ARC seems to be involved in both LTD and
LTP and is localized to dendrites.[87,88] However, ARC might
have another role during plasticity. ARC has viral group‐speciﬁc
antigen (Gag) polyprotein elements and with these GAG
elements, ARC is able to form capsids.[89,90] These capsids
can then be exocytosed in exosomes (Figure 4), which is a
communication method between neurons and between
neurons and glia.[91] Most interestingly, the ARC capsids
contain ARC RNA but they are also able to encapsidate other
mRNAs.[89,90] In the Drosophila neuromuscular junction, the
trans‐synaptic transport of ARC is required for synaptic
plasticity.[89] Interestingly, the mRNA in the capsids can be
translated in the destination neuron.[89,90] Local synaptic
translation of mRNA in neurons allows synaptic changes to
be started at a very early timepoint, while in the meantime
proteins are newly synthesized in the cell body. In summary,
there seems to be a conserved mechanism of trans‐synaptic
communication by viral‐like proteins, but it remains unclear
whether speciﬁc mRNAs are shuﬄed between neurons and
how the process is regulated.
2.7. BDNF and Feedback Loop Deﬁne Engram Cells
A further prominent CREB target is the brain‐derived
neurotrophic factor (BDNF), which is involved in the develop-
ment of the nervous system and is also a key regulator in
synaptic plasticity.[34,53,92] BDNF is secreted and may act in an
autocrine and paracrine fashion[93] (Figure 4). Interestingly,
Figure 4. Feedback loops, BDNF and ARC: binding of BDNF to its receptor activates CREB‐mediated transcription. BDNF is one target gene of CREB
and can initiate a feedback loop. BDNF can also bind to receptors in the paracrine area. Another feedback loop exists between CREB and its target
c‐fos and depends on phosphorylation by the kinase ERK. The mRNA of the CREB target ARC is transported to the dendrites where it can form
capsids, which are loaded into exosomes. Exosomes can be uptaken by the synapse and the encapsid mRNA can be translated.
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BDNF is both upstream and downstream of CREB.[34,93,94]
Whereas BDNF expression is mediated by CREB, binding of
BDNF to its receptor tropomyosin receptor kinase B (TrkB)
triggers CREB activity. In fact, there seems to be a positive
feedback loop involving BDNF, CREB, and C/EPB.[95] Training
leads to the release of BDNF, which can activate CREB‐
mediated gene expression via its receptor TrkB. The CREB
target C/EBP leads to BDNF transcription[34,95] (Figure 4). This
loop may have the function of sustaining CREB activity for later
integration of information while keeping CREB activity
restricted. In fact, studies in rodents show that consolidation
is still not ﬁnished 24 h after memory formation.[12]
BDNF can also activate the AKT–TOR signaling pathway,
which is involved in translation regulation, thereby aﬀecting
CREB downstream processes.[96,97]
In Drosophila there seems to be a feedback loop between CREB
and the ﬂy homolog of c‐fos, kayak. The expression of c‐fos is
dependent on CREB, whereas c‐fos is required for CREB
expression (Figure 4). However, this cycling only occurs in a
subset of MB cells, which were described as being important for
LTM consolidation.[98] Thus, cells with the CREB‐c‐fos loop seem
to be the engram cells for the formation of a memory. In
mammals, it was shown that cells with higher CREB activity are
preferably recruited as engram cells in the amygdala.[99–101]
Moreover, CREB activity seems to cycle for autoregulatory
feedback.[102] In conclusion, the loop between CREB and c‐fos
or CREB and BDNF may keep CREB active during the
consolidation process without allowing the constitutive activity of
CREB. Furthermore, because BDNF is secreted it might also
inhibit neighboring neurons from being part of the engram or it
might recruit them by signaling pathways downstream of TrkB.
Because only a few engram cells encode a memory,[1,102]
studying only a small population of cells will be beneﬁcial for
understanding the memory consolidation process. Recently, a
conditional knockout line for CREB was established in the
ﬂy.[25] To this end, the coding sequence of CREB was ﬂanked by
ﬂippase recognition target (FRT) sites. Using a ﬂippase under
the control of the powerful Gal4–UAS system, CREB can be
knocked out in speciﬁc cells. With these knockout ﬂies, it was
conﬁrmed that CREB in the MB is important for LTM
formation. It was also shown that only a subset of MB neurons
is required for LTM. Furthermore, the downstream neurons of
these cells require CREB for LTM.[25] Thus, this ﬂy‐line allows
the study of memory‐relevant cells in greater detail.
In summary, it seems that CREB is cycling with a
downstream factor during LTM consolidation in engram cells.
2.8. Cofactors Allow Switching between Memory Phases
CREB can use both CBP/p300 and CRTC as cofactors for gene
transcription. Which cofactor is required for which process or
context is thus a critical distinction in the regulation of CREB
activity.[15,44–47] Interestingly, CBP can function as a histone
acetyltransferase (HAT), and therefore activate promotor regions.[39]
CBP furthermore only binds to CREB after it has been
phosphorylated at Ser‐133.[34,45] This speaks more for a role of
CBP in mediating the ﬁrst transcription wave after CREB becomes
activated. CRTC, however, can bind to CREB independent of its
phosphorylation status.[46,47,103] Moreover, upon an increase in
cAMP or Ca2+, CRTC is dephosphorylated and transported from
synapses to the nucleus.[24,103,104] One kinase that phosphorylates
CRTC to keep it in the cytoplasm is the 5′‐AMP‐activated protein
kinase (AMPK), which is involved in regulating energy metabolism
depending on adenosine triphosphate/adenosine monophosphate
(ATP/AMP) levels.[103,105] This would be another pathway to allow
or continue consolidation when the cell is under no particular
pressure. Nevertheless, both CRTC and CBP are required for
LTM.[23,24,45] Recently, the requirement of the cofactors during LTM
formation and maintenance was analyzed in the fruit ﬂy.[23] LTM
formation seems to require CREB and CBP. However, early
maintenance requires CRTC, thus suggesting a switch in the
cofactor between the two states of LTM[23] (Figure 3B).
Interestingly, CRTC1 in mammals is also reported to be
required for maintenance, so this change in the cofactor during
memory consolidation seems to be conserved.[24] This switch in
the cofactor might be a simple mechanism for changing gene
expression programs. Furthermore, because CRTC can be
shuﬄed from the synapse to the nucleus,[24,103,104] it may relay
further information required for maintenance.
The maintenance for even longer timepoints is completely
independent of CREB and requires the TF Beadex (bx), a
homolog to mammalian Lim domain only transcription factors
(LMO)[106] (Figure 3B). It seems that CREB and CRTC induce
bx expression during memory consolidation, whereas bx
autoregulates itself and other maintenance genes for a long‐
lasting memory.[23] The separation of regulatory networks and
maintenance networks by exchanging the involved factors could
be a conserved mechanism in LTM consolidation.
Interestingly, LMO4 has a CRE site within its promotor,
making it a possible CREB target.[49] In fear memories, LMO4
might act as a repressor, whereas in reward learning it was
associated with motivational signiﬁcance.[72,73] Future studies of
LMO4 will provide insight into how these diﬀerent functions
may be achieved.
Both cofactors have also been reported to interact with IEG
TFs such as c‐jun or fos.[35,45,103] By using diﬀerent combina-
tions between CREB, the IEG transcription regulators and the
cofactors, the downstream transcription program could be
dynamically and variably adjusted. Diﬀerent cofactors and
transcription regulators might diﬀer in their promotor pre-
ference or in the ability to recruit the polymerase complex or
histone modiﬁers to start transcription. Understanding how
these factors interact by using immune precipitation and other
proteomics techniques will help us untangle the gene
regulatory network.
2.9. CREB Is Not the Only Transcription Regulator
CREB is considered a crucial TF in learning and memory.
Although the regulation of CREB activity provides diﬀerent
mechanisms to regulate gene expression, TFs usually work in
combination. Surprisingly, little is known of other TFs in
learning and memory. CREB belongs to the bZIP class of TFs,
which can form heterodimers between each other, hence the
combination of bZIPs could alter the expressed genes by
changing aﬃnity to promotor elements (PEs).[15,26,27]
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Furthermore, it is known from mouse models that upon
downregulation of CREB there is compensation by CREM and
possibly other transcription regulators.[35,47,82] In mouse, the
way in which memories are impaired seems to be related to the
genetic background and severity of the CREB mutation.[82]
There are reports from mouse and ﬂy that CREB might be
dispensable for at least some memory forms, or brain regions
as knockdown of CREB did not impair LTM.[107–109] However,
in Drosophila, recent data truly speak for the role of CREB in
memory consolidation.[25] In mammals, we cannot exclude that
there might be other factors that could initiate memory
consolidation. But it is also possible that loss of CREB is
compensated by CREM and other TFs as well as reconﬁgura-
tion of the neuronal network circumventing neurons lacking
CREB. Therefore, analyzing other TFs might shed some light
on these conﬂicting observations.
One possible further transcription regulator might be serum
response factor (SRF), given that its promotor recognition
sequence is found in the c‐fos promotor, other IEGs, and
CamKII. Furthermore, cytoskeleton genes are downstream of
SRF so this transcription regulator could be responsible for
structural plasticity.[35,51,110]
It was shown that manipulation of SRF aﬀects memory,[35]
and furthermore that SRF could regulate its own expression
and interact with diﬀerent cofactors for activation or repression
of gene expression.[35,111] In this regard, SRF has many features
in common with CREB.
Another candidate for regulating gene expression is nuclear
factor‐κB (NF‐κB), mostly known for its role in immune‐related
processes.[112] There are reports of memory impairment in NF‐κB
mutants, and moreover, NF‐κB seems to be localized at synapses,
so it may be transported activity‐dependent to the nucleus to aﬀect
gene expression.[12,68] Taken together, these observations suggest
that NF‐κBmight have a dual role as a signaling molecule and as a
transcription regulator. Moreover, CREB could work in combina-
tion with tissue‐ or cell‐type‐speciﬁc TFs to regulate the genes
required in a cell upon stimulation.
It would be useful to see whether known promotor
sequences appear together with the CRE sequence in mem-
ory‐related genes to get a better understanding of the gene
regulatory system. However, the question is, how these
transcription regulators interact with each other, i.e., whether
they regulate the genes together and are redundant or whether
each of them controls a speciﬁc subset. Monitoring their activity
or comparing ChIP data and transcriptomic data could help to
shed some light on this.
2.10. Epigenetic Mechanisms Are Gaining Importance
Gene expression is not only regulated at the transcriptional
level but also by mechanisms controlling the chromatin state.
DNA is packed in a compact structure by histone proteins.
Whereas histone deacetylases (HDACs) are tightening DNA
packing, making it less accessible for the RNA polymerase,
HATs loosen it to allow transcription of the respective
genes.[21,113] As shown in Table 1 histone‐modifying genes
are likely targets of CREB, indicating a role of epigenetic
mechanisms in memory consolidation.[23,49,56] Furthermore,
the CREB cofactor CBP is a known HAT, thereby strengthening
this idea.[39] It has been shown that inhibitors for HDACs
enhance memory, conﬁrming the important role of histone
modiﬁcation in learning and memory.[21] Furthermore, histone
modiﬁcations at memory genes aﬀect their expression, thereby
inﬂuencing consolidation.[21,114] The CREB cofactors CBP and
p300 have the ability to acetylate histones, so they may play a
role in making genes accessible for transcription.[115–117]
Interestingly, depending on the training intensity, diﬀerent
HATs are recruited. Weak training involved CBP, whereas in
strong training CBP was replaced at a later timepoint by KAT5/
Tip60.[24] This result also ﬁts with a recent study in Drosophila.
The LTM formation seems to require CBP, but LTM
maintenance at an early point requires GCN5 and Tip60; at
even later timepoints only Tip60 is required.[23] Recently, it was
shown that CCCTC‐binding factor (CTCF) is required for the
correct expression of memory genes: in CTCF mutants ARC
and BDNF expression is misregulated. This happens because,
without CTCF DNA loops between distinct gene regulatory
elements are not established.[118] The importance of chromatin
remodeling is further highlighted by the observation in
Drosophila that distinct members of the SWI/SNF aﬀect
memory diﬀerently.[119]
Besides histone modiﬁcations and chromatin remodeling,
gene expression can also be regulated by DNA methylation,
which inhibits RNA expression.[22] Interestingly, the CRE
element can be methylated because it has CpG islands.[49,64]
Hence, DNA methylation can directly regulate CREB‐depen-
dent gene expression. This could aﬀect CREB target genes,
such as c‐fos, indicating that methylation might be a common
way to regulate learning genes.[22,120]
An additional level of protein expression modulation is
regulation at the mRNA level. The stability of mRNA determines
how much protein is synthesized from a given transcript. Especially
in neurons, mRNAs are bound by RNA‐binding proteins (RBPs),
and the so‐called RNA granula made of RNA and associated
proteins are transported to synaptic regions.[13,121] In synapses,
these mRNAs can be translated directly where the protein will be
required and inﬂuence synaptic plasticity.[122] These early‐translated
proteins might be a quick way to modulate a synapse before the
newly synthesized proteins from the cell body arrive. Sequences in
the 3′‐untranslated region (3′‐UTR) of mRNAs act as a kind of
postal zip code, deﬁning which RBP proteins can bind and where
the mRNA will be localized: diﬀerent polyadenylation signals can
regulate mRNA localization in diﬀerent subcellular compart-
ments.[122] In Drosophila, the RBPs pumillo, orb, and staufen are
implicated in learning and memory, highlighting the importance of
local synaptic translation for memory formation.[58,123,124] Moreover,
data from diﬀerent model organism show that noncoding RNAs
such as microRNAs (miRNAs) are required for the regulation of
plasticity‐involved genes. It is known that miRNA can repress the
translation of target mRNAs or even lead to mRNA cleavage, thus
reducing the amount of translated proteins.[125–128] Given that
neuronal communication happens at a much faster rate and is
more dynamic than protein biosynthesis, miRNAs could help to
adjust protein levels in this ever‐changing environment. However,
miRNAs are also found at synapses, where they repress local
synaptic translation until neuronal activity requires it.[125–128] Some
miRNAs seem to be directly expressed in response to CREB,
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highlighting their role in memory formation.[126] Moreover, mRNA
can be regulated by further mechanisms: Drosophila orb2A mRNA
retains an intron and is not translated; however, neuronal activity
leads to removal of the intron and translation of orb2A.[129]
Interestingly, orb2A belongs to the cytoplasmic polyadenylation
element‐binding proteins (CPEB), which regulate the polyadenyla-
tion of mRNAs, thereby regulating their translation.[130] A further
mechanism to regulate mRNA is the nonsense‐mediated decay
with the exon‐junction complex, leading to mRNA degradation.[131]
In summary, mRNA stability, localization, and translation rate
are regulated by multiple mechanisms, leading to a diverse pool of
mRNAs, while adjusting synapses independent of transcription.
2.11. Multilevel Gene Regulatory Network in LTM Consolidation
The consolidation of memory to stable and long‐lasting
memories is a tightly regulated multistep process. The
consolidation of LTM is very energy‐intensive process, requir-
ing protein biosynthesis.[132] Therefore, memory storage only
occurs in favorable conditions. The transcription regulator
CREB is a master regulator of the expression of memory genes.
It integrates signaling from neuronal pathway as well as stress
signaling and other processes[19] (Figure 5). However, the
transcriptional regulators SRF and NF‐κB as well as yet
unknown players might also contribute to the induction of
LTM formation.[35,68] The main group of CREB targets
comprises other transcription regulators that turn on the next
level of transcription (Figure 5). Comparisons between species,
brain regions, and diﬀerent methods to induce LTM formation
suggest that there is a conserved core program of CREB targets
similar to the immediately early genes c‐fos, egr1, ARC, as well
as neurotransmitter subunits and other synaptic proteins.
However, there might also be CREB targets speciﬁc for memory
type and the underlying synaptic changes or cell type. The
transcription programs are ﬁnely regulated by the interaction of
multiple transcription regulators, post‐translational modiﬁca-
tions, the usage of cofactors and epigenetic mechanisms. This
allows the system to respond ﬂexibly to changes or diﬀerent
contexts as well as being adaptable to diﬀerent neuron types.
Moreover, it allows the integration of multiple or conﬂicting
memory traces by gradually adapting the activity of CREB and
other transcription regulators.
Feed‐forward loops between CREB and c‐fos and/or
BDNF[95,98] deﬁne the engram cell and allow the integration
of delayed information, e.g., the nutritional value of food or
during spaced training. Nevertheless, later timepoints of
maintenance seem to require, as a ﬁrst step, a change in
cofactors and later also a change in transcriptional regulators.
In the ﬂy, bx seems to be the regulator of the maintenance gene
regulatory network[23] (Figure 5). Thus, there are two regulatory
networks for the diﬀerent time phases of memory. This allows
changing the transcriptional program from genes inducing
LTM formation to genes for maintenance, making CREB
available for the next memory events. However, what the
maintenance network looks like in mammals is not yet known.
Recent studies suggested the atypical PKMζ as well as the
CAMKII as important factors in this process.[133–135] The bx
homolog Lmo4 might be a good starting point for a TF.
Secreted factors such as BDNF and ARC could deﬁne the
neurons participating within a memory trace and coordi-
nate them.
Epigenetic mechanisms, as well as tight regulation of mRNA
maturation, stability, localization, and translation, add to the
dynamics and diversity required in fast‐acting neurons. There-
fore, memory consolidation is regulated on all steps of protein
biosynthesis.
Although many possible memory genes are known, their
detailed function is not resolved. Because a memory trace is
encoded only by a few cells, techniques that can manipulate
Figure 5. Simpliﬁed gene regulatory network in LTM formation and maintenance: the molecular switch CREB turns on the LTM regulatory network
depending on the context. CREB targets include TFs that induce the second round of transcription and neuronal genes associated with plasticity.
Components of signaling pathways will inﬂuence both CREB and CREB target genes. Bx is then responsible for the maintenance genes.
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small groups of cells are required to untangle the gene
regulatory network.
3. Conclusion and Outlook
Consolidation of LTM is a highly regulated yet dynamic and ﬂexible
process. Moreover, it is also strongly conserved, as demonstrated by
similar conclusions resulting from diverse scientiﬁc approach
studies in diﬀerent species and brain regions. At least two
hierarchical levels of gene transcription exist. The ﬁrst one is
mainly regulated by CREB along with other transcription regulators
such as SRF or NF‐κB and is a permissive signal to start memory
consolidation. The second level is a combination of TFs and other
proteins enacting the synaptic changes and memory storage, e.g.,
the IEGs c‐fos, egr1, or ARC. A variety of principles are required to
carry out the task of memory consolidation: signaling pathways,
feedback mechanisms between the key players CREB, c‐fos, and
BDNF, the cofactors CBP and CRTCs, epigenetic mechanisms and
mRNA processing, and synaptic translation. Progressing from LTM
formation to long‐lasting maintenance requires a switch in
cofactors and transcription regulators. Long‐lasting memories seem
to become independent from the consolidation gene regulatory
network centered on CREB and exploit a diﬀerent maintenance
network. Althoughmany genes are described to be involved in LTM
formation and/or maintenance, it remains a mystery how they
function and how they act together to manage the whole process.
Comparing and testing putative CREB targets and memory genes
discovered in the various screenings might help to untangle the
LTM consolidation program. Newer techniques allowing analysis of
only a few neurons or even single neurons might help to shed light
on the processes that consolidate and maintain memories.
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